FDA Inspection 1221056 — LifeShare Blood Center

LifeShare Blood Center — FEI 2370879

The FDA completed an inspection of LifeShare Blood Center on August 31, 2023 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 31, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Shreveport, LA (United States)